Saturday, April 26, 2025
HomeNews

News

BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO

BioMarin Pharmaceutical Inc. presented data at The Endocrine Society Annual Meeting, ENDO 2022, demonstrating the Company's ongoing commitment to understanding the lifetime impact of...

Zynex Announces Change of Auditor

Zynex, Inc. ("Zynex or the "Company), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management,...

Orpyx Launches Orpyx SI Flex Sensory Insoles and Diabetes Healthspan Extension Care Model

Orpyx Medical Technologies Inc., a digital health company focused on extending the health span of patients with diabetes, announced the launch of the Orpyx...

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis

Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced that it has entered into a...

EyeControl Expands R&D Program with EyeControl-Pro for Delirium

EyeControl is developing the EyeControl-Pro, an AI-based, smart, screenless and wearable, eye-tracking communication solution for Delirium reduction. The company will display its new investigational...
0FansLike
0FollowersFollow
spot_img

Hot Topics